Two Sigma Investments
SEEL

Two Sigma Investments’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Two Sigma Investments’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-102
Closed -$7.73K – 3421
2024
Q1 		$7.73K Sell
102
-95
-48% -$12.5K ﹤0.01% 2962
2023
Q4 		$35.1K Buy
+197
New +$96.9K ﹤0.01% 3023
2022
Q4 		– Sell
-19
Closed -$76K – 3132
2022
Q3 		$76K Sell
19
-109
-85% -$429K ﹤0.01% 2267
2022
Q2 		$333K Sell
128
-134
-51% -$349K ﹤0.01% 1988
2022
Q1 		$844K Sell
262
-64
-20% -$275K ﹤0.01% 1786
2021
Q4 		$2.04M Buy
326
+71
+28% +$545K ﹤0.01% 1904
2021
Q3 		$2.36M Sell
255
-215
-46% -$1.85M 0.01% 1833
2021
Q2 		$4.76M Buy
+470
New +$7.72M 0.01% 1238

Other funds holding SEEL

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CHA
Carmichael Hill & Associates Gaithersburg, Maryland $282M AUM 32.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments's SEEL Position: Q2 2024 in Review

Two Sigma Investments sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q2 2024, closing a stake of 102 shares — an estimated $7.73K sold.

Two Sigma Investments first reported a position in SEEL in Q2 2021 and held it in 8 quarters. The position peaked at $4.76M in Q2 2021. 18 funds tracked by Wall St. Rank hold SEEL as of Q2 2024.

  • Two Sigma Investments reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 102 Seelos Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $7.73K.
  • Two Sigma Investments first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Two Sigma Investments's Seelos Therapeutics, Inc. Common Stock position peaked at $4.76M in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.